These updates are republished press releases and communications from members of the Science|Business Network. Network Updates can be sent to [email protected] and [email protected]. To know if your content piece qualifies as Network Update, check the editorial guidelines here.

A picture of health?

AstraZeneca’s outrageously high bid for Cambridge Antibody Technology underscores the heat rising in the biotech market.

Political problems dog research budget

A nagging political question still hovers over the EU funding debate: should the roughly €54 billion be spent exclusively on Europe's established crème de la scientific crème?